Oral spray for preventing, quickly diagnosing and treating dental caries and preparation method thereof

The oral spray formed by phosphate buffered solution of molecular probes and xylitol dissolved in dimethyl sulfoxide, solves the simplicity, cost and efficiency of caries diagnosis and treatment, and achieves rapid diagnosis and treatment , avoid harm to symbiotic bacteria and reduce medical treatment costs.

CN116440077BActive Publication Date: 2024-12-03SHANDONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310267812.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-15
Publication Date
2024-12-03
Estimated Expiration
2043-03-15

AI Technical Summary

Technical Problem

Existing caries diagnosis methods lack simple, low-cost, fast and effective means, and conventional methods may damage tissue, and the abuse of antibiotics leads to bacterial resistance. The existing treatment methods are expensive, complex and time-consuming.

Method used

Molecular probe [4-(2-{4-[bis-(4-methoxy-phenyl)-amino]-phenyl}-vinyl)-1-methyl-pyridinium]+PF6-( MeOTpy) and xylitol in phosphate (PBS) buffer solution of dimethyl sulfoxide (DMSO) to form an oral spray for rapid diagnosis and treatment of caries, fluorescence imaging and disease-causing through white light irradiation bacteria.

Benefits of technology

It has achieved rapid diagnosis and treatment of caries, avoided killing of symbiotic bacteria, reduced diagnosis and treatment costs, simplified the diagnosis and treatment process, and showed good prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116440077B_ABST
    Figure CN116440077B_ABST
Patent Text Reader

Abstract

The invention discloses a method for preparing an oral spray for preventing and treating dental caries, comprising: preparing a molecular probe [4-(2-{4-[bis-(4-methoxy-phenyl)-amino]-phenyl}-vinyl)-1-methyl-pyridinium] + PF6 ‑ (MeOTpy) and xylitol are dissolved in a PBS buffer solution containing 0.1% dimethyl sulfoxide (DMSO) by volume to obtain an oral spray for preventing and treating dental caries; the structural formula of the molecular probe is: #imgabs0# The oral spray provided by the present invention can quickly and effectively image and kill oral bacterial biofilm in real time, prevent and treat dental caries, and refresh breath. At the same time, it avoids killing some symbiotic bacteria in the oral cavity, reduces the cost of dental caries diagnosis and treatment, simplifies the diagnosis and treatment process, and shows good prospects in dental caries diagnosis and treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of pharmaceutical preparations, and in particular to an oral spray for preventing, quickly diagnosing and treating dental caries and a preparation method thereof. Background Art

[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Dental caries is a common bacterial infection of the oral cavity. Oral bacteria adhere to the surface of the teeth to form bacterial biofilms. The main pathogen is Streptococcus mutans (S. mutans). Severe dental caries may cause other oral diseases, such as pulpitis, apical periodontitis, and tooth loss. In addition, oral diseases can lead to the spread of local infections, such as chronic nephritis, endocarditis, and sepsis. Therefore, early diagnosis and treatment of dental caries is crucial to human health.

[0004] With the development of science and technology, antibiotics are being developed and applied to the treatment of bacterial infectious diseases. However, the excessive abuse of antibiotics has prompted the evolution of bacteria and the development of drug resistance. Furthermore, the current clinical diagnosis method is limited to detailed visual inspection by dentists using sharp tooth probes, which lacks objectivity and inevitably damages tissues. Other supporting diagnostic methods such as imaging examinations, staining techniques and ultrasound techniques are expensive, complicated and time-consuming. Therefore, it is necessary to develop a simple, low-cost, fast and effective means of diagnosing and treating caries. Summary of the invention

[0005] In order to overcome the above problems, the present invention provides an oral spray for preventing, quickly diagnosing and treating dental caries and a preparation method thereof.

[0006] In order to achieve the above technical objectives, the present invention adopts the following technical solutions:

[0007] The first aspect of the present invention provides a method for preparing an oral spray for preventing, rapidly diagnosing and treating dental caries, wherein the molecular probe [4-(2-{4-[bis-(4-methoxy-phenyl)-amino]-phenyl}-vinyl)-1-methyl-pyridinium] + PF6 - (MeOTpy) and xylitol are dissolved in a phosphate buffered saline (PBS) solution containing dimethyl sulfoxide (DMSO) to obtain an oral spray for preventing, rapidly diagnosing and treating dental caries;

[0008] The structural formula of the molecular probe is:

[0009]

[0010] The second aspect of the present invention provides an oral spray prepared by the above method for preparing an oral spray.

[0011] The beneficial effects of the present invention are:

[0012] (1) The probe molecule prepared by the present invention has a simple synthesis method and can quickly bind to the dental caries pathogen S. mutans. Under white light irradiation, the molecules bound to the bacteria emit fluorescence and generate reactive oxygen in situ, thereby achieving imaging and killing of the pathogenic bacteria.

[0013] (2) Xylitol is a sweetener that has the functions of freshening breath, replenishing energy, and promoting saliva secretion. At the same time, xylitol cannot be fermented and utilized by oral streptococci, and can inhibit bacterial growth and acid production to prevent tooth decay. The combination of xylitol and probe molecules in the preparation of oral sprays achieves the clinical goals of dental caries diagnosis, prevention, and treatment.

[0014] Dimethyl sulfoxide (DMSO) is a medical grade polar solvent that improves the solubility of the probe molecule and is miscible in water, which is beneficial to the stability of the spray. It also has certain anti-inflammatory and local analgesic effects.

[0015] (3) The oral spray provided by the present invention can quickly and effectively image and kill oral caries pathogens in real time and control caries biofilm, prevent and treat caries, and freshen breath. At the same time, it avoids killing some symbiotic bacteria in the oral cavity, achieving precise treatment. At the same time, it reduces the cost of caries diagnosis and treatment, simplifies the diagnosis and treatment process, and shows good prospects in caries diagnosis and treatment. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] The drawings in the specification, which constitute a part of the present application, are used to provide further understanding of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute improper limitations on the present application.

[0017] Figure 1 is the mass spectrum of MeOTpy;

[0018] Figure 2 This is the rapid fluorescence imaging of MeOTpy on the pathogenic bacteria S. mutans and a symbiotic bacterium Escherichia coli (E. coli) at 30S, 5min, 10min and 20min;

[0019] Figure 3 This is the fluorescence response kinetics experimental diagram of MeOTpy to the pathogenic bacteria S. mutans;

[0020] Figure 4The images of active oxygen generated by photodynamics, where A is the fluorescence spectrum of MeOTpy changing with time under illumination conditions; B is the fluorescence spectrum of DCFH changing with time under illumination conditions; C is the fluorescence spectrum of MeOTpy and DCFH changing with time under illumination conditions; D is the fluorescence intensity data output image of MeOTpy, DCFH and MeOTpy+DCFH changing with time under illumination conditions;

[0021] Figure 5 These are images of MeOTpy photodynamic killing of pathogenic bacteria, where A is the sterilization image of MeOTpy against pathogenic bacteria Streptococcus mutans; B is the data output of MeOTpy’s sterilization rate against pathogenic bacteria Streptococcus mutans; C is the sterilization image of MeOTpy against symbiotic bacteria Escherichia coli; D is the data output of MeOTpy’s sterilization rate against symbiotic bacteria Escherichia coli;

[0022] Figure 6 The fluorescence imaging images of the oral spray of the present invention include healthy and carious human teeth in vitro, A is the fluorescence imaging of healthy and carious human teeth in vitro by the oral spray of the present invention; B is the output image of the fluorescence intensity data of the teeth in the healthy group and the disease group;

[0023] Figure 7 This is a picture of fluorescence imaging and photodynamic killing of in vitro caries biofilm by the oral spray of the present invention. DETAILED DESCRIPTION

[0024] It should be noted that the following detailed descriptions are all illustrative and are intended to provide further explanation of the present application; unless otherwise specified, all technical and scientific terms used in the present application have the same meanings as commonly understood by ordinary technicians in the technical field to which the present application belongs.

[0025] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application; as used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, they indicate the presence of features, steps, operations, devices, components and / or their combinations.

[0026] Specifically, the present invention is achieved through the following technical solutions:

[0027] The first typical embodiment of the present invention provides a method for preparing an oral spray for preventing, rapidly diagnosing and treating dental caries, wherein the molecular probe [4-(2-{4-[bis-(4-methoxy-phenyl)-amino]-phenyl}-vinyl)-1-methyl-pyridinium] + PF6 -(MeOTpy) and xylitol are dissolved in a phosphate buffered saline (PBS) solution containing dimethyl sulfoxide (DMSO) to obtain an oral spray for preventing, rapidly diagnosing and treating dental caries;

[0028] The structural formula of the molecular probe is:

[0029]

[0030]

[0031] In one or more embodiments, the synthesis method of MeOTpy comprises the following steps:

[0032] (1) Dissolve 4-[bis(4-methoxyphenyl)amino]benzaldehyde and 1,4-dimethylpyridine iodide in ethanol, reflux at 80°C for 9 to 11 hours under nitrogen protection, and after the reaction is completed, cool to room temperature, wash, and obtain intermediate Z;

[0033] (2) Dissolve the intermediate Z in acetone, then add a saturated KPF6 solution, and stir at room temperature for 1 to 2 hours. After the reaction is complete, remove the solvent acetone, filter to obtain a brown solid, wash, dry, and purify to obtain MeOTpy;

[0034]

[0035] Preferably, in step (1), the molar ratio of 4-[bis(4-methoxyphenyl)amino]benzaldehyde and 1,4-dimethylpyridine iodide dissolved in ethanol is 5:6.

[0036] Preferably, the amount of ethanol in step (1) is 100 to 200 times the equivalent of the reactants.

[0037] Preferably, 3 to 5 drops of piperidine are added as a catalyst in step (1).

[0038] Preferably, the washing method in step (1) is to pour into a large amount of ether, and then filter to obtain intermediate Z.

[0039] Preferably, the amount of acetone in step (2) is 50 to 100 times the equivalent of the reactants.

[0040] Preferably, the molar ratio of the intermediate Z in step (2) to KPF6 is 1:10 to 1:100.

[0041] Preferably, the mass fraction of the saturated KPF6 solution in step (2) is 20.9%.

[0042] Preferably, the method of removing the solvent acetone in step (2) is vacuum rotation, the pressure is 0.01-0.1 MPa, and the temperature is 30-35°C.

[0043] Preferably, the washing condition in step (2) is washing with water 3 to 5 times.

[0044] Preferably, the drying conditions in step (2) are a drying temperature of 40 to 60° C. and a pressure of 0.01 to 0.1 MPa in a vacuum drying oven.

[0045] Preferably, the purification method in step (2) is: purification by silica gel GF254 thin layer chromatography, and the elution solvent is dichloromethane / methanol with a volume ratio of 10:1.

[0046] In one or more embodiments, the PBS buffer solution contains 0.001-0.1% dimethyl sulfoxide by volume, preferably 0.1%.

[0047] In one or more embodiments, the mass ratio of MeOTpy to xylitol is 43:2000.

[0048] In one or more embodiments, the concentration of the PBS buffer solution is 0.01 mol / L and the pH is 7.4.

[0049] In one or more embodiments, the mass ratio of MeOTpy to PBS buffer solution is 1:28000.

[0050] A second typical embodiment of the present invention provides an oral spray prepared by the above-mentioned method for preparing an oral spray.

[0051] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.

[0052] Example 1

[0053] Synthesis and characterization of MeOTpy:

[0054] The specific synthesis steps are as follows:

[0055]

[0056] 0.333 g of 4-[bis(4-methoxyphenyl)amino]benzaldehyde and 0.129 g of 1,4-iodinated dimethylpyridine were dissolved in 20 ml of ethanol, and then 4 drops of piperidine were added. The mixture was refluxed and stirred at 80°C for 10 hours under nitrogen protection. After the reaction was completed, the mixture was cooled to room temperature, and then poured into a large amount of ether and filtered to obtain intermediate Z.

[0057] 0.2g of intermediate Z was redissolved in acetone, and then 10ml of saturated KPF6 (mass fraction of saturated solution: 20.9%) solution was added to the mixture and stirred at room temperature for 1 hour. After the reaction was completed, the acetone was removed by rotary evaporation at a pressure of 0.05MPa and a temperature of 35°C. The brown solid was filtered out, washed with water and dried in a vacuum drying oven at a temperature of 50°C and a pressure of 0.05MPa. It was purified by thin layer chromatography using silica gel GF254, using dichloromethane / methanol with a volume ratio of 10:1 as the elution solvent to obtain a brown product MeOTpy (67.4%). Figure 1 As shown, MeOTpy was characterized by mass spectrometry, HRMS (ESI) m / z calcd.for C 28 H 27 N2O2, [M-PF6] + calculated 423.21, found 423.20.

[0058] Example 2

[0059] This example explores the rapid fluorescence imaging of the pathogenic bacteria S. mutans by MeOTpy prepared in Example 1.

[0060] S. mutans was cultured on solid agar plates at 37°C for 8 h, and E. coli was recovered in liquid medium LB at a shaking speed of 100 rpm for 10 h, then transferred to solid agar plates and grown at 37°C for 8 h. Both bacteria were collected using sterile cotton swabs and diluted to 2 × 10 in 0.85% NaCl solution. 8 CFU (OD600=0.257). S. mutans and E. coli were mixed and incubated in 7 μM MeOTpy for 30 seconds, 5 minutes, 10 minutes and 20 minutes, and then time-dependent confocal fluorescence imaging was performed.

[0061] like Figure 2 As shown, MeOTpy can light up S. mutans within 30 seconds of being added to the bacterial culture medium, but there is almost no fluorescence response to E. coli.

[0062] The fluorescence response dynamics of MeOTpy to S. mutans was recorded using a fluorescence spectrometer. Figure 3 It was shown that the fluorescence intensity reached a plateau 60 seconds after MeOTpy was mixed with S. mutans, thus, MeOTpy could rapidly image S. mutans.

[0063] Example 3

[0064] This embodiment investigates the photodynamic bactericidal performance of MeOTpy prepared in Example 1.

[0065] DCFH is used to detect the 2 ) under physiological conditions (PBS buffer, 0.01M, pH 7.4) of MeOTpy. Specifically, the fluorescence of DCFH will be enhanced after the reaction with ROS. 1μL MeOTpy mother solution (7mM in DMSO) and 1μL DCFH mother solution (1.0mM, 10μL) were added to PBS buffer (989μL), and the fluorescence intensity of DCFH at 523nm was recorded as a function of white light irradiation time (488nm excitation). Figure 4 As shown in the figure, MeOTpy has a strong ability to generate ROS under white light irradiation.

[0066] Example 4

[0067] This example explores the photodynamic killing of pathogenic bacteria S. mutans by MeOTpy prepared in Example 1.

[0068] The traditional plate counting method was used to investigate the antibacterial properties of MeOTpy. MeOTpy at different concentrations (0 μM, 1 μM, 3 μM, 5 μM, and 7 μM) was used to treat the main dental caries pathogen S. mutans and a commensal bacterium Escherichia coli (10 7 CFU / mL) were incubated at 37°C in 0.85% NaCl for 1 min, then the bacteria were treated under white light or in the dark for 15 min. The treated bacterial suspension was serially diluted 1000 times (10 4 CFU / mL), and then 100 μL of the diluted bacteria was spread on a solid agar plate, the treated bacteria were cultured at 37°C for 12 h, and the number of colonies formed in each group was counted to evaluate the antibacterial effect.

[0069] like Figure 5 As shown in the figure, without MeOTpy treatment, S. mutans and E. coli can grow and reproduce normally on agar plates in the dark or light conditions. MeOTpy has no obvious dark toxicity to all bacteria, but S. mutans can be effectively killed under MeOTpy and white light irradiation, which shows that MeOTpy can effectively kill pathogens by photodynamics while avoiding killing other symbiotic bacteria.

[0070] Example 5

[0071] Preparation of oral spray: 0.0057 g MeOTpy prepared in Example 1 and 20 g xylitol were dissolved in 1 L of 0.01 M PBS buffer solution containing 0.1% DMSO by mass and pH 7.4 to obtain an oral spray.

[0072] Example 6

[0073] This example uses the oral spray prepared in Example 5 to test the dental caries biofilm in the ex vivo teeth:

[0074] Healthy and decayed ex vivo teeth were collected, and the oral spray prepared in Example 5 was sprayed on the surface of the ex vivo teeth, and then fluorescent imaging of the healthy and decayed ex vivo teeth was performed. Figure 6 As shown, the oral spray can perform fluorescence imaging of teeth. The fluorescence intensity of the caries group is higher than that of the healthy group, and it can indicate the potential sites of caries macroscopically. Therefore, the oral spray can evaluate the degree of caries.

[0075] Example 7

[0076] The oral spray prepared in Example 5 was used to kill dental caries bacterial biofilm:

[0077] Dental plaque from children with severe dental caries was collected and inoculated on the surface of healthy tooth enamel, and high sugar culture was used to form bacterial biofilm. The oral spray prepared in Example 5 was used to treat the bacterial biofilm for 15 minutes in the dark and light conditions. SYTO60 was used to fluorescently stain all bacteria in the bacterial biofilm, and SYTOX-Green was used to stain dead bacteria in the bacterial biofilm. Figure 7 As shown, the confocal fluorescence imaging results showed that only orange fluorescence of SYTO60 was observed in the bacterial biofilm treated with the oral spray under dark conditions, but orange fluorescence of SYTO60 and green fluorescence of SYTOX-Green were observed in the bacterial biofilm treated with the oral spray under light, indicating that the oral spray can effectively kill bacterial biofilms.

[0078] Therefore, the oral spray provided by the present invention can quickly and effectively image and kill oral bacterial biofilm in real time, prevent and treat dental caries, and freshen breath. At the same time, it avoids killing some symbiotic bacteria in the oral cavity, reduces the cost of dental caries diagnosis and treatment, simplifies the diagnosis and treatment process, and shows good prospects in dental caries diagnosis and treatment.

[0079] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing an oral spray for preventing, rapidly diagnosing and treating dental caries, characterized in that: The method comprises: introducing a molecular probe [4-(2-{4-[bis-(4-methoxy-phenyl)-amino]-phenyl}-vinyl)-1-methyl-pyridinium] + PF6 - and xylitol are dissolved in a phosphate buffer solution containing dimethyl sulfoxide to obtain an oral spray for preventing, quickly diagnosing and treating dental caries; The phosphate buffer solution is a PBS buffer solution; The structural formula of the molecular probe is: MeOTpy; The synthesis method of MeOTpy comprises the following steps: (1) Dissolve 4-[bis(4-methoxyphenyl)amino]benzaldehyde and 1,4-dimethylpyridine iodide in ethanol, reflux at 80°C for 9-11 hours under nitrogen protection. After the reaction is completed, cool to room temperature and wash to obtain intermediate Z; (2) Dissolve the intermediate Z in acetone, then add saturated KPF6 solution and stir at room temperature for 1-2 hours. After the reaction is completed, remove the solvent acetone and filter to obtain a brown solid, which is then washed, dried and purified to obtain MeOTpy; 。 2. The preparation method according to claim 1, characterized in that In step (1), 3 to 5 drops of piperidine are added as a catalyst.

3. The preparation method according to claim 1, characterized in that: The washing method in step (1) is to pour into a large amount of ether, and then filter to obtain the intermediate Z.

4. The preparation method according to claim 1, characterized in that: The amount of acetone in step (2) is 50 to 100 times the equivalent of the reactants; Alternatively, the molar ratio of the intermediate Z in step (2) to KPF6 is 1:10 to 1:

100.

5. The preparation method according to claim 1, characterized in that: The method of removing the solvent acetone in step (2) is vacuum rotation, the pressure is 0.01-0.1 MPa, and the temperature is 30-35°C; Or, the washing condition in step (2) is washing with water 3 to 5 times; Alternatively, the drying conditions in step (2) are as follows: the drying temperature is 40-60° C. and the pressure is 0.01-0.1 MPa in a vacuum drying oven.

6. The preparation method according to claim 1, characterized in that: The purification method in step (2) is: purification by silica gel GF254 thin layer chromatography, and the elution solvent is dichloromethane / methanol with a volume ratio of 10:

1.

7. The preparation method according to claim 1, characterized in that: The PBS buffer solution contains 0.001-0.1% dimethyl sulfoxide by volume; Alternatively, the concentration of the PBS buffer solution is 0.01 mol / L and the pH is 7.

4.

8. The preparation method according to claim 1, characterized in that: The PBS buffer solution contains 0.1% dimethyl sulfoxide by volume.

9. An oral spray prepared by the preparation method according to any one of claims 1 to 8.